Healthcare Services

Viral Gastroenteritis Market Revenue Expected to Reach $9.19 Billion by 2030 with 5.5% CAGR

April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Viral Gastroenteritis Market At The End Of The 2026–2030 Forecast Period?

The viral gastroenteritis market size has demonstrated robust growth over recent years. It is anticipated to increase from $7.06 billion in 2025 to $7.43 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.1%. This historical expansion can be attributed to advancements in public health awareness, broader access to healthcare, the presence of fundamental diagnostic tools, the rising utilization of oral rehydration solutions, and improved disease reporting mechanisms.

The market for viral gastroenteritis is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $9.2 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. Several factors are expected to drive this growth during the forecast period, including increased funding for infectious disease surveillance, a growing need for swift point-of-care diagnostic tools, the broadening scope of vaccination and preventive initiatives, a heightened emphasis on pediatric health services, and the wider uptake of digital platforms for disease tracking. Key trends anticipated during this period involve a greater concentration on rapid diagnostic testing, an escalating requirement for supportive care treatments, a reinforced commitment to infection control and prevention strategies, the expanded application of oral rehydration and zinc therapies, and improved monitoring of viral outbreaks.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

What Primary Drivers Are Shaping The Development Of The Viral Gastroenteritis Market?

The future expansion of the viral gastroenteritis market is anticipated due to the rising occurrence of gastrointestinal conditions. Gastrointestinal (GI) disorders are defined as illnesses affecting any segment of the gastrointestinal tract. Individuals afflicted with viral gastroenteritis receive assistance through specific drugs and diagnostic therapies, providing suitable medication. An illustrative example from September 2023 highlights this trend: the Impact of IBD Report 2023, issued by the IBD Clinical and Research Centre, a Canada-based organization focused on enhancing the lives of patients with Crohn’s disease and ulcerative colitis, noted that in 2023, over 320,000 individuals in Canada were diagnosed with inflammatory bowel disease (IBD), exhibiting a prevalence of 825 per 100,000. This prevalence is forecasted to grow by 2.44% annually, leading to an estimated 470,000 Canadians, or 1.1% of the population, living with IBD by 2035. Consequently, the expanding incidence of gastrointestinal disorders is fueling the expansion of the viral gastroenteritis market.

What Segment Types Make Up The Viral Gastroenteritis Market?

The viral gastroenteritis market covered in this report is segmented –

1) By Drugs: Antibiotics, Antacids, Antimotility Agents, Others Drugs

2) By Diagnosis: Physical Examination, Rapid Stool Test

3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

Subsegments:

1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins

2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate

3) By Antimotility Agents: Loperamide, Diphenoxylate

4) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics

Which Market Trends Are Creating New Opportunities In The Viral Gastroenteritis Market?

Leading companies within the viral gastroenteritis market are developing new products, such as PCR kits for gastrointestinal infectious diseases, to secure a competitive advantage. Polymerase Chain Reaction (PCR) kits are molecular biology tools created for amplifying and detecting specific DNA sequences. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based molecular diagnostic solutions firm, introduced 10 Real-Time PCR Kits engineered for precise identification of gastrointestinal pathogens, establishing a comprehensive Total PCR Solution when combined with their extraction solution and PCR system. These Real-Time PCR Kits address a spectrum of bacterial, viral, and parasitic pathogens linked to gastrointestinal infections, encompassing conditions caused by bacterial pathogens like Campylobacter, Salmonella, Shigella, and Clostridioides difficile, alongside viral agents such as Adenovirus, Rotavirus, Astrovirus, and Norovirus. This innovative offering provides an optimized process from sample pre-processing to PCR amplification analysis.

Who Are The Key Players Driving Competition In The Viral Gastroenteritis Market?

Major companies operating in the viral gastroenteritis market are Pfizer Inc., Sanofi S A, Abbott Laboratories, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Mylan N V, Dr Reddys Laboratories Ltd, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, ANI Pharmaceuticals Inc, Merck Sharp & Dohme Corp, Abbvie Inc, AstraZeneca Plc, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Roche Holding AG, BristolMyersSquibb Company, Amgen Inc, Eli Lilly and Company, Novartis AG, Johnson and Johnson, Moderna Inc, Bharat Biotech International Ltd

Read the full viral gastroenteritis market report here:

https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

How Does The Viral Gastroenteritis Market Perform Across Major Global Regions?

North America was the largest region in the viral gastroenteritis market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Viral Gastroenteritis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12127&type=smp

Browse Through More Reports Similar to the Global Viral Gastroenteritis Market 2026, By The Business Research Company

Viral Hepatitis Global Market Report

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Gastrointestinal Pathogen Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

Oral Expectorant Global Market Report

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795